JR Pharma Engineering Holding ApS: Financial statements 2023
CVR: 42396273
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
JR Pharma Engineering Holding ApS (CVR 42396273) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 0 and a net result of DKK 1,200,461. Equity in the 2023 report amounted to DKK 1,200,461. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 1,200,461
- Equity
- DKK 1,200,461
- Total Assets
- DKK 1,200,461
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout JR Pharma Engineering Holding ApS
JR Pharma Engineering Holding ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jimmy Rønne Jensen. The company is owned by Jimmy Rønne Jensen. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK 554,386 and a net result of DKK 560,509 compared with DKK 601,978 the year before. Equity in the 2026 report amounted to DKK 3,012,480.